MARKET MOVERS
š“ DOWNGRADES
$NVDA: Downgraded to Market Perform by Bernstein SocGen Group; PT cut to $200 from $400
$NVDA: Downgraded to Perform by Oppenheimer; PT withdrawn
$NVDA: Downgraded to Market Perform by William Blair
$NVDA: Downgraded to In Line by Evercore ISI; PT lowered to $186
š PRICE TARGET CUT
$NVDA: PT cut to $205 from $315 by Stifel
$NVDA: PT cut to $225 from $285 by Citi
$NVDA: PT cut to $230 from $330 by RBC Capital
$NVDA: PT cut to $280 from $350 by BofA Securities
$NVDA: PT cut to $225 from $300 by Yorkville Ives
šµ RATING REITERATIONS
$NVDA: Outperform reiterated by Mizuho; PT $250
$NVDA: Buy reiterated by UBS; PT $300
$NVDA: Strong Buy reiterated by Raymond James; PT $515
$NVDA: Overweight reiterated by Piper Sandler; PT $300
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
